Skip to main content
. 2018 May 1;9(33):23237–23252. doi: 10.18632/oncotarget.25296

Table 3. Relationships between clinicopathological features of ESCC and CLIC1 expression.

Variable IHC score p value * IHC score p value *
< 0.9 ≥ 0.9 ≤ 0.1 > 0.1
(n=52) (n=9) (n=20) (n=41)
Gender
 Male 44 8 0.739 17 35 0.97
 Female 8 1 3 6
Age
 <65 years 32 3 0.114 15 20 0.048
 ≥65 years 20 6 5 21
Recurrence
 Positive 19 5 0.281 10 14 0.236
 Negative 33 4 10 27
Tumor length
 <50 cm 36 5 0.42 13 28 0.798
 ≥50 cm 16 4 7 13
Histological type
 Well/Moderately 37 7 0.682 10 34 0.008
 Poorly 15 2 10 7
Lymphatic invasion
 Negative 24 5 0.602 10 19 0.583
 Positive 28 4 10 22
Venous invasion
 Negative 26 6 0.355 11 21 0.781
 Positive 26 3 9 20
Pathological depth of the tumor
 pT1 22 5 0.46 8 19 0.639
 pT2-3 30 4 12 22
Pathological lymph node metastasis
 pN0 22 5 0.46 7 20 0.306
 pN1-3 30 4 13 21

* Fisher’s exact test.